UFP Technologies, Inc. (NASDAQ: UFPT) is a Healthcare company (Medical - Devices) with a market capitalization of $2.3B. The Maz Rating grades it against the other companies in its sector.
UFP Technologies, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $297.49, UFP Technologies, Inc. trades at 29.8x trailing earnings, 3.5x sales and 4.7x book value, with an EV/EBITDA of 20.8. Over the last twelve months it generated about $654M of revenue and $77M of net income. It runs a gross margin of 28.9%, an operating margin of 15.5% and a net margin of 11.8%. It shows return on equity of 16.9%, return on invested capital of 13.2% and a free cash flow yield of 2.8%. On the balance sheet: a debt-to-equity ratio of 0.24 and a current ratio of 2.98. Over the past 52 weeks the share price ranged from $173.86 to $342.11, with a beta of 1.10.
UFP Technologies, Inc. does not currently pay a dividend.
2 Wall Street analyst ratings cover the stock: 2 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.